Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhaled steroids: are they all created equal?

Joseph D Spahn1, Stanley J Szefler

  • 1Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado 80206, USA.

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed
Summary

New inhaled steroids and delivery devices offer alternatives to older inhalers. More research is needed to compare their benefits and risks for optimal patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality Among Adults with Subspecialist-Treated Severe Asthma: A Descriptive Analysis from the Observational CHRONICLE Study.

Journal of asthma and allergy·2026
Same author

50 years on: how inhaled corticosteroids have changed the treatment of asthma.

The Lancet. Respiratory medicine·2026
Same author

PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort.

The Journal of allergy and clinical immunology·2026
Same author

What Magnitude of Change in FEV<sub>1</sub> is Associated With Increased Odds for Asthma Exacerbation and Loss of Control?

Pediatric pulmonology·2026
Same author

Corticosteroid stewardship: How much corticosteroid is too much?

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same author

Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polyps.

Clinical and experimental immunology·2025

Area of Science:

  • Pulmonology
  • Pharmacology
  • Drug Delivery Systems

Background:

  • Hydrochlorofluorocarbon (HCFC) propellant-based inhalers are being phased out.
  • New inhaled steroid formulations and delivery devices are emerging.
  • Limited data exists on the comparative efficacy and safety of these new options.

Purpose of the Study:

  • To review the landscape of new inhaled steroid preparations and delivery devices.
  • To highlight the need for comparative efficacy and safety data.
  • To inform clinicians on selecting optimal inhaled steroid therapies.

Main Methods:

  • Review of recent studies on inhaled steroid comparative efficacy.
  • Focus on standardized measures of systemic effects.
  • Analysis of different delivery system types (hydrofluoroalkane inhalers, dry powder inhalers).

Main Results:

  • Several methods are emerging to assess comparative efficacy.
  • Systemic effects are a key metric for comparison.
  • Understanding device-specific differences is crucial.

Conclusions:

  • Physicians need to be aware of the distinctions between various inhaled steroid and delivery device combinations.
  • Selection should aim to maximize therapeutic benefits.
  • Minimizing adverse effects is a primary consideration in treatment choice.

Related Experiment Videos